Altimmune to Participate at Two Upcoming Investor Conferences
Altimmune (Nasdaq: ALT) has announced its participation in two upcoming investor conferences. The company's management team will be present at the Annual Evercore HealthCONx Conference in Coral Gables, FL on December 3, 2024, featuring a fireside chat at 10:50 a.m. ET, and the Piper Sandler Annual Healthcare Conference in New York, NY on December 4, 2024, with a fireside chat scheduled for 3:30 p.m. ET. Both sessions will be available via webcast through the Events section of Altimmune's website. The team will also be available for one-on-one meetings during these events.
Altimmune (Nasdaq: ALT) ha annunciato la sua partecipazione a due importanti conferenze per investitori. Il team dirigenziale dell'azienda sarà presente alla Conferenza Annuale Evercore HealthCONx a Coral Gables, FL, il 3 dicembre 2024, con un incontro pomeridiano alle 10:50 ora dell'est, e alla Conferenza Annuale Healthcare di Piper Sandler a New York, NY, il 4 dicembre 2024, con un incontro pormeridiano previsto per le 15:30 ora dell'est. Entrambi gli eventi saranno disponibili in webcast nella sezione Eventi del sito web di Altimmune. Il team sarà inoltre disponibile per incontri individuali durante queste manifestazioni.
Altimmune (Nasdaq: ALT) ha anunciado su participación en dos próximas conferencias para inversores. El equipo de gestión de la empresa estará presente en la Conferencia Anual Evercore HealthCONx en Coral Gables, FL, el 3 de diciembre de 2024, con una charla programada a las 10:50 a.m. ET, y en la Conferencia Anual de Atención Médica de Piper Sandler en Nueva York, NY, el 4 de diciembre de 2024, con una charla programada para las 3:30 p.m. ET. Ambas sesiones estarán disponibles a través de una transmisión en vivo en la sección de Eventos del sitio web de Altimmune. El equipo también estará disponible para reuniones uno a uno durante estos eventos.
Altimmune (Nasdaq: ALT)는 두 개의 투자자 회의에 참여한다고 발표했습니다. 회사의 경영팀은 2024년 12월 3일, FL주 코랄 게이블스에서 열리는 연례 Evercore HealthCONx 콘퍼런스에 참석하며, 오전 10:50 ET에 화로 대화를 진행할 예정입니다. 또한 2024년 12월 4일, NY주 뉴욕에서 열리는 Piper Sandler 연례 헬스케어 콘퍼런스에서도 오후 3:30 ET에 화로 대화를 예정하고 있습니다. 두 세션 모두 Altimmune 웹사이트의 이벤트 섹션을 통해 웹캐스트로 제공됩니다. 팀은 이 행사 동안 일대일 회의도 진행할 수 있습니다.
Altimmune (Nasdaq: ALT) a annoncé sa participation à deux conférences pour investisseurs à venir. L'équipe de direction de l'entreprise sera présente à la Conférence Annuelle Evercore HealthCONx à Coral Gables, FL, le 3 décembre 2024, avec une discussion prévue à 10h50 ET, et à la Conférence Annuelle de Santé Piper Sandler à New York, NY, le 4 décembre 2024, avec une discussion programmée à 15h30 ET. Les deux sessions seront accessibles par webdiffusion via la section Événements du site web d'Altimmune. L'équipe sera également disponible pour des réunions individuelles durant ces événements.
Altimmune (Nasdaq: ALT) hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. Das Managementteam des Unternehmens wird am 3. Dezember 2024 um 10:50 Uhr ET bei der Jahreskonferenz Evercore HealthCONx in Coral Gables, FL, anwesend sein und am 4. Dezember 2024 um 15:30 Uhr ET an der Piper Sandler Jahreskonferenz für Gesundheitswesen in New York, NY, teilnehmen. Beide Sitzungen werden über einen Webcast im Bereich Veranstaltungen der Altimmune-Website verfügbar sein. Das Team wird auch während dieser Veranstaltungen für Einzelgespräche zur Verfügung stehen.
- None.
- None.
GAITHERSBURG, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate and be available for 1x1 meetings at the following investor conferences:
- Annual Evercore HealthCONx Conference (Coral Gables, FL)
Tuesday, December 3, 2024
Fireside Chat at 10:50 a.m. Eastern Time
- Piper Sandler Annual Healthcare Conference (New York, NY)
Wednesday, December 4, 2024
Fireside Chat at 3:30 p.m. Eastern Time
The sessions will be webcast and can be accessed by visiting the Events section of the Altimmune website.
About Altimmune
Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH. For more information, please visit www.altimmune.com.
Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter
Company Contact:
Greg Weaver
Chief Financial Officer
Phone: 240-654-1450
ir@altimmune.com
Investor Contact:
Lee Roth
Burns McClellan
Phone: 646-382-3403
lroth@burnsmc.com
Media Contact:
Danielle Cantey
Inizio Evoke, Biotech
Phone: 619-826-4657
Danielle.cantey@inizioevoke.com
This press release was published by a CLEAR® Verified individual.
FAQ
When is Altimmune (ALT) presenting at the Evercore HealthCONx Conference 2024?
What time is Altimmune's (ALT) presentation at the Piper Sandler Healthcare Conference 2024?
How can investors watch Altimmune's (ALT) conference presentations in December 2024?
Will Altimmune (ALT) management be available for individual meetings at the December 2024 conferences?
